Led by BPI France and Temasek Holdings, a number of top sovereign wealth funds have increased their healthcare investments over the past five years.
In February, AstraZeneca subsidiary MedImmune spun out Viela Bio — a biotech company targeting inflammation and autoimmune diseases.
Singapore-based sovereign wealth fund Temasek Holdings participated in Viela’s $250M Series A round, along with a consortium of Chinese investors.
Temasek is among some of the world’s top sovereign wealth funds (SWFs) — or government owned investment vehicles — increasing their private market investments in healthcare.
Using the CB Insights platform, we identified some of the biggest sovereign wealth funds (based on assets under management) and where they have been placing their private market healthcare bets since 2013.